Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Early clinical markers of aggressive multiple sclerosis.

Journal: Brain : a journal of neurology

Publication Year: 2020

Authors & Co-authors:  Malpas Charles B CB Manouchehrinia Ali A Sharmin Sifat S Roos Izanne I Horakova Dana D Havrdova Eva Kubala EK Trojano Maria M Izquierdo Guillermo G Eichau Sara S Bergamaschi Roberto R

Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 

Authors & Co-authors:  Sharmin Sifat S Malpas Charles B CB Roos Izanne I Diouf Ibrahima I Alroughani Raed R Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S Horakova Dana D Havrdova Eva K EK

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.

Journal: Brain : a journal of neurology

Publication Year: 2023

Authors & Co-authors:  Sharmin Sifat S Roos Izanne I Simpson-Yap Steve S Malpas Charles C Sánchez Marina M MM Ozakbas Serkan S Horakova Dana D Havrdova Eva K EK Patti Francesco F Alroughani Raed R

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R